Trial Profile
A Randomized, Double-Blind, Multi-center, Placebo-Controlled, Combination Study to Evaluate the Urate-Lowering Activity, Safety, and Potential Pharmacokinetic Interaction of Oral BCX4208 and Allopurinol Administered in Subjects With Gout.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ulodesine (Primary) ; Allopurinol
- Indications Gout
- Focus Adverse reactions; Therapeutic Use
- 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 28 May 2011 Pooled efficacy analysis results presented at the 12th Annual Congress of the European League Against Rheumatism.
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.